Shaanxi Kanghui Pharm Co Ltd (603139) — Capital Reinvestment Ratio
Shaanxi Kanghui Pharm Co Ltd (603139) has a Capital Reinvestment Ratio of 3.44x as of September 2025, meaning it reinvests 3% of its operating cash flow (CN¥7.14 Million) in capital expenditures (CN¥24.57 Million). Check 603139 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shaanxi Kanghui Pharm Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Shaanxi Kanghui Pharm Co Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Shaanxi Kanghui Pharm Co Ltd.
Annual Capital Reinvestment Ratio for Shaanxi Kanghui Pharm Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Shaanxi Kanghui Pharm Co Ltd from 2012 to 2024. See 603139 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.25x | CN¥37.29 Million | CN¥46.66 Million | ▼ -54.3% |
| 2022 | 2.74x | CN¥50.43 Million | CN¥138.13 Million | ▼ -93.0% |
| 2021 | 39.13x | CN¥7.42 Million | CN¥290.30 Million | ▲ +1295.1% |
| 2020 | 2.80x | CN¥93.72 Million | CN¥262.89 Million | ▲ +270.3% |
| 2019 | 0.76x | CN¥107.53 Million | CN¥81.45 Million | ▲ +750.0% |
| 2018 | 0.09x | CN¥62.64 Million | CN¥5.58 Million | ▲ +8.2% |
| 2017 | 0.08x | CN¥43.60 Million | CN¥3.59 Million | ▲ +22.9% |
| 2016 | 0.07x | CN¥71.72 Million | CN¥4.81 Million | ▼ -84.8% |
| 2015 | 0.44x | CN¥28.50 Million | CN¥12.60 Million | ▼ -48.0% |
| 2014 | 0.85x | CN¥22.72 Million | CN¥19.30 Million | ▼ -34.2% |
| 2013 | 1.29x | CN¥39.35 Million | CN¥50.77 Million | ▲ +86.3% |
| 2012 | 0.69x | CN¥16.12 Million | CN¥11.17 Million | — |